1. DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment. Issue 11 (2nd September 2020) Authors: McMullen, Michelle; Karakasis, Katherine; Loembe, Bienvenu; Dean, Emma; Parr, Graem; Oza, Amit M Journal: International journal of gynecological cancer Issue: Volume 30:Issue 11(2020) Page Start: 1824 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment. Issue 11 (2nd September 2020) Authors: McMullen, Michelle; Karakasis, Katherine; Loembe, Bienvenu; Dean, Emma; Parr, Graem; Oza, Amit M Journal: International journal of gynecological cancer Issue: Volume 30:Issue 11(2020) Page Start: 1824 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment. Issue 11 (November 2020) Authors: McMullen, Michelle; Karakasis, Katherine; Loembe, Bienvenu; Dean, Emma; Parr, Graem; Oza, Amit M Journal: International journal of gynecological cancer Issue: Volume 30:Issue 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment. Issue 11 (2nd September 2020) Authors: McMullen, Michelle; Karakasis, Katherine; Loembe, Bienvenu; Dean, Emma; Parr, Graem; Oza, Amit M Journal: International journal of gynecological cancer Issue: Volume 30:Issue 11(2020) Page Start: 1824 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗